Trial · NCT01665937
STA-9090 in Patients With Advanced Hepatocellular Cancer
NCT01665937, Phase 1, Completed, Massachusetts General Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. STA-9090 in Patients With Advanced Hepatocellular Cancer. Trials, record NCT01665937. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01665937
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- STA-9090 in Patients With Advanced Hepatocellular Cancer
- NCT number
- NCT01665937
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 16 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Hepatocellular Carcinoma
- Interventions
- STA-9090
- First posted
- 2012-08-16
- Last updated
- 2018-04-25
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Phase 2 dose of STA 9090 given once weekly in patients with advanced hepatocellular carcinoma | 3 years | Dose escalation/de-escalation study will be performed in order to determine the Phase 2 dose of STA-9090 given once weekly in patients with advanced hepatocellular carcinoma. The dose limiting toxicities will be determined at each dose level. |
| Secondary | Number of patients with adverse events when treated with STA 9090 for advanced hepatocellular carcinoma | 3 years | To assess the safety and tolerability of STA9090 in patients with advanced hepatocellular carcinoma. |
| Secondary | Median time to progression (TTP) | 3 years | To determine median time to progression (TTP) for patients treated at recommended Phase 2 dose. |
| Secondary | Median progression-free survival (PFS) | 3 years | To determine median progression-free survival (PFS) for patients treated at recommended Phase 2 dose. |
| Secondary | Response Rate | 3 years | To determine objective tumor response rate using RECIST criteria |
| Secondary | Overall Survival | 3 years | To determine overall survival |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01665937
GET https://conductscience.org/api/trials/v1/NCT01665937/registered